Across TCGA pan-cancer cohorts, LINC01696 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of LINC01696’s most consistent transcriptional readouts.
The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where LINC01696 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC01696 is over-expressed in tumor.
HNSC are the cancer types where LINC01696 tumor–normal differential expression is most reproducible.